Incidence of and risk factors for vaginal cuff dehiscence following total laparoscopic hysterectomy: a monocentric hospital analysis by Radosa, Julia Caroline et al.
Vol.:(0123456789) 
Archives of Gynecology and Obstetrics 
https://doi.org/10.1007/s00404-021-06064-0
GENERAL GYNECOLOGY
Incidence of and risk factors for vaginal cuff dehiscence following total 
laparoscopic hysterectomy: a monocentric hospital analysis
Julia Caroline Radosa1  · Marc Philipp Radosa2 · Julia Sarah Maria Zimmermann1 · Eva‑Marie Braun1 · 
Sebastian Findeklee1 · Annette Wieczorek1 · Lisa Stotz1 · Amr Hamza1 · Ferenc Zoltan Takacs1 · Uda Mareke Risius3 · 
Christoph Gerlinger1 · Christoph Georg Radosa4 · Stefan Wagenpfeil5 · Erich‑Franz Solomayer1
Received: 18 January 2021 / Accepted: 9 April 2021 
© The Author(s) 2021
Abstract
Purpose Vaginal cuff dehiscence (VCD) is one of the major surgical complications following hysterectomy with data on 
incidence rates varying largely and studies assessing risk factors being sparse with contradictive results. The aim of this study 
was to assess the incidence rate of and risk factors for VCD in a homogenous cohort of women treated for benign uterine 
pathologies via total laparoscopic hysterectomy (TLH) with standardized follow-up.
Methods All patients undergoing TLH at the Department of Gynecology and Obstetrics, Saarland University Hospital 
between November 2010 and February 2019 were retrospectively identified from a prospectively maintained service database.
Results VCD occurred in 18 (2.9%) of 617 patients included. In univariate and multivariate analyses, a lower level of surgeon 
laparoscopic expertise (odds ratio 3.19, 95% confidence interval (CI) 1.0–9.38; p = 0.03) and lower weight of removed uterus 
(odds ratio 0.99, 95% CI 0.98–0.99; p = 0.02) were associated positively with the risk of VCD.
Conclusion In this homogenous cohort undergoing TLH, laparoscopic expertise and uterine weight influenced the risk of 
postoperative VCD. These findings might help to further reduce the rate of this complication.
Keywords Vaginal cuff dehiscence · Total laparoscopic hysterectomy · Laparoscopic surgery · Risk factors · Complication · 
Gynecologic surgery
Introduction
Hysterectomy ranks among the most commonly performed 
gynecological surgical procedures [1]. Nearly 150,000 hys-
terectomies are performed annually in Germany [2].
Eighty-five percent of these surgeries are elective inter-
ventions, performed due to benign uterine pathologies [3]. 
Vaginal hysterectomy has been the traditional standard-of-
care procedure for surgical uterus removal, but a gradual 
shift has occurred in surgical gynecology in the past 2 dec-
ades from vaginal and abdominal approaches to minimally 
invasive techniques, with increased performance of total 
laparoscopic hysterectomy (TLH) [4]. Major advantages of 
TLH over open procedures are reduced postoperative pain, 
faster recovery, and shorter hospitalization [5]. However, 
a notable disadvantage is the higher incidence of vaginal 
cuff dehiscence (VCD), defined as the separation of the 
previously sutured vaginal incision [6]. Although VCD is 
a rare complication, the evisceration of abdominal or pel-
vic organs through the vaginal breach can lead to serious 
sequelae, such as bowel injury, peritonitis, necrosis, and 
sepsis; regardless of its extent, VCD necessitates additional 
surgery in most cases [7, 8]. VCD occurs significantly more 
frequently after TLH (0.64–5.4%) than after abdominal 
(0.38%), vaginal (0.11%), and laparoscopically assisted 
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(0.46–1.5%) procedures [9, 10]. Electrosurgery, previous 
radiation therapy, pelvic floor defects, and early postopera-
tive sexual intercourse have been associated with the occur-
rence of VCD in general, but data on surgery-related risk 
factors for post-TLH VCD are sparse and contradictory [2, 
11, 12]. Given the paucity of data and the high variation on 
the incidence of VCD following TLH in the current litera-
ture, we aimed to assess the frequency of and risk factors for 
VCD following TLH performed for benign uterine patholo-
gies in a large cohort treated at a laparoscopic tertiary refer-
ral center.
Materials and methods
All patients who underwent TLH due to benign uterine dis-
orders between November 2010 and February 2019 at the 
Department of Gynecology and Obstetrics, Saarland Univer-
sity Hospital, Homburg, Germany, were identified retrospec-
tively through a prospectively maintained service database. 
The study was approved by the Saarland Institutional Review 
Board (Reference No. 85/16) and registered with the Ger-
man Clinical Trials Register (DRKS) (No. DRKS00009904).
All methods were carried out in accordance with respec-
tive guidelines and regulations. All TLHs were performed 
under general anesthesia at Department of Gynecology and 
Obstetrics at Saarland University Hospital Homburg, Ger-
many, where the procedure has been the standard surgical 
approach for hysterectomy since 2009. The surgical tech-
niques applied are described in detail elsewhere [13–15]. 
Preoperatively, all patients provided medical histories and 
underwent gynecological examination, transvaginal ultra-
sound, and ultrasound of the kidneys. Basic laboratory tests 
were performed on admission.
All procedures were performed using a vaginal manip-
ulator (Hohl; Karl Storz SE & Co. KG, Tuttlingen, Ger-
many). Colpotomy of the vaginal fornix was performed with 
a monopolar hook (Karl Storz SE & Co. KG, Tuttlingen, 
Germany). The vaginal vault was closed with single-layer 
laparoscopic suturing (single knot or running) using Vic-
ryl 1-CT-1 (Ethicon Inc., Somerville, NJ, USA) and an 
intracorporeal knot technique. All patients received periop-
erative antibiotics (cefuroxime, 1.5 g; Fresenius Kabi, Bad 
Homburg, Germany), indwelling urinary catheters, and 
low-molecular-weight heparin (enoxaparin sodium, 40 mg; 
Sanofi, Paris, France) as thromboembolism prophylaxis 
postoperatively. All patients underwent standardized follow-
up, including gynecological examination and transvaginal 
sonography, at 6 weeks postoperatively, and were inter-
viewed by telephone about the occurrence of VCD. Patients 
with incomplete datasets, including missing follow-up infor-
mation, were excluded from the study.
VCD was defined as full-thickness separation of the ante-
rior and posterior edges of the vaginal cuff, with or without 
bowel evisceration categorized as complete when the sepa-
ration involved the entire length of the vaginal vault and as 
partial when it involved only part of the incision [11, 16]. 
Evisceration was defined as the expulsion of abdominal con-
tent through a vaginal cuff defect. VCD repair was conducted 
laparoscopically with complete inspection of the abdominal 
cavity for hematoma, abscess, or bowel injury, followed by 
irrigation, excision of necrotic tissue, and re-suturing using 
single-knot technique with Vicryl 1-CT-1 (Ethicon Inc., 
Somerville, USA). In cases of minimal dehiscence and no 
clinical or sonographic suspicion of hematoma, abscess, or 
bowel injury, vaginal repair with single-knot suturing was 
performed.
Clinical data comprising patients’ age (years), body mass 
index (kg/m2), menopausal status, childbirth (number, mode 
of delivery) and surgeries performed in the past (measured 
by a surgery score: 0 points: no previous surgery, 1 point: 
previous laparoscopic surgery 2 points: open surgery, e.g., 
laparotomy, cesarean section) described by Boosz et al. and 
surgical parameters such as duration of surgery (minutes), 
performance of consecutive adhesiolysis or ureterolysis, 
suturing technique (single stitches vs. running non-overcast 
suture), duration of surgery (minutes), postoperative com-
plications (according to the Clavien–Dindo classification 
of surgical complications), interval between surgery and 
first sexual intercourse (weeks), time between surgery and 
detection of VCD (days) and laparoscopic expertise of the 
surgeon assessed according to the GESEA program (Gynae-
cologic Endoscopic Surgical Education and Assessment) of 
the European Academy of Gynaecological Surgery and the 
European Society for Gynaecologic Endoscopy (ESGE) 
(GESEA level 1 (Bachelor) and GESEA level 2 [minimal 
invasive Gynaecological Surgeon (MIGS)] [17–20].
Statistical analysis
Data were collected in an Excel database (Excel 2014, 
Microsoft Corporation, Redmond, WA, USA). The Kolmog-
orov–Smirnov test was used to assess normality distribution 
for quantitative variables. As the data were non-normally 
distributed, we used the Mann–Whitney U test to assess 
differences between groups. For categorical variables, we 
used Pearson’s Chi-squared test for group comparisons. For 
multiple analysis, binary logistic regression with stepwise 
forward and backward selection was used to identify factors 
and possible confounders associated with the occurrence of 
VCD. Statistical tests were two-sided and subject to a sig-
nificance level of 5%. Due to the explorative nature of the 
investigation, we did not account for the issue of multiple 
testing and thus report unadjusted P values. The statistical 
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analyses were performed using SPSS (Version 19; SPSS 
Inc., Chicago, IL, USA).
Results
Patient characteristics
Six hundred and sixty-three patients who received TLH 
for benign uterine pathologies between November 2010 
and September 2018 at the Department of Gynecology 
and Obstetrics, Saarland University Hospital, Homburg, 
Germany were identified from the service database. Four 
patients were excluded because of malignant final histol-
ogy reports, 18 patients were excluded because of non-
attendance of 6 weeks postoperative follow-up visits, and 
24 patients were excluded because of missing further post-
operative information on occurrence of VCD, leaving a 
total of 617 patients included in the final analysis. Detailed 
patient characteristics and surgical parameters are shown in 
Tables 1 and 2. Postoperative VCD occurred in 18 patients 
(incidence rate, 2.9%). Median time between surgery and 
detection of VCD were 12 days (range 0–69). Patients with 
VCD presented with vaginal bleeding or discharge (n = 12), 
abdominal pain (n = 5), and vaginal pressure (n = 1). Three 
patients had complete VCD, with the evisceration of abdom-
inal content through the dehiscence in two cases. Sixteen 
patients with VCD required re-operation, via laparoscopy in 
13 patients and via single-knot vaginal closure in 3 patients 
with minor dehiscence (Table 3).
Risk factor analysis
In the univariate analysis, uterine weight and surgeon’s 
laparoscopic expertise were associated with the incidence 
of VCD. The median weight of removed uterus was signifi-
cantly lesser among patients with than among those with-
out VCD [91 g, (range 55–321) vs. 171 g, (range 19–2148), 
P ≤ 0.01]. Significantly more patients with than without 
VCD were operated on by level 1 surgeons [14 (78%) vs. 
4 (22%), P ≤ 0.01] (Table 4). On multivariate analysis, the 
risk of VCD was associated with a lower level of surgeon 
laparoscopic expertise [odds ratio 3.19 (95% CI 1.0–9.38); 
P = 0.03] and lesser weight of removed uterus [odds ratio 
Table 1  Patient’s characteristics (n = 617)
n = 617
Median (Min–Max)
Age (years) 47 (26–82)
BMI (kg/m2) 25.7 (19–54.6)
Parity 1 (0–7)
Number of vaginal deliveries 1 (0–7)






Main indications for hysterectomy (%)
 Symptomatic uterine fibroids 366 (59)
 Endometriosis 110 (18)
 Cervical dysplasia 49 (8)
 Uterine prolaps 48 (8)
 Other 44 (7)
Table 2  Surgical outcomes (n = 617)
Median (Min–Max)
Surgical parameters
 Duration of surgery (min) 109 (40–390)
 Hemoglobin drop (g/dl) 1.1 (0–6.9)
 Postoperative hospitalization (days) 3 (1–25)





 GESEA level I 297 (48)
 GESEA level II 320 (52)
Suturing technique
 Single knot suture 519 (84)
 Running suture 98 (16)
Postoperative complications (Clavien–Dindo)
 Mild complications (I–II) 16 (2.6)
 Severe complications (III–V) 20 (3.2)
First postoperative sexual intercourse < 6 weeks 119 (19)
Table 3  Incidence and presentation of VCD (n = 617)
Vaginal cuff dehiscence (VCD) 18 (2.9 %)




Symptom presented with for VCD
 Vaginal bleeding 10 (55 %)
 Pain 7 (39 %)
 Vaginal pressure 1 (6 %)
Type of dehiscence
 Partial dehiscence 15 (83 %)
 Complete dehiscence 3 (17 %)
Evisceration
 Yes 2 (11 %)
 No 16 (89 %)
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0.99 (95% CI 0.98–0.99); P = 0.02]. The incidence of VCD 
was not associated with the duration of surgery, body mass 
index, or suturing technique (Table 5).
Discussion
In designing the present study, we sought to evaluate 
incidence and risk factors of VCD following total lapa-
roscopic hysterectomy for benign uterine pathologies in 
a large cohort treated at a laparoscopic tertiary referral 
center, with a standardized follow-up. We found a rate 
of 2.9% for vaginal cuff dehiscence, which is in line with 
Table 4  Univariate analysis 
of patient’s characteristics and 
surgical outcome patients with 
vaginal cuff dehiscence (VCD) 








Age (years) 46 (26–82) 45 (29–72) 0.75
BMI (kg/m2) 25.8 (19–54.6) 24.7 (20.6–48.2) 0.29
Parity 1 (0–7) 1.5 (0–3) 0.68
Number of vaginal deliveries 1 (0–7) 0.5 (0–2) 0.52
Previous surgery score 1 (0–16) 1 (0–14) 0.13
N (%)
Smoker 105 (18) 4 (22) 0.36
Menopausal status 0.49
 Pre-/perimenopausal 480 (80) 14 (78)
 Postmenopausal 119 (20) 4 (22)
Main indications for hysterectomy (%) 0.26
 Symptomatic uterine fibroids 359 (60) 7 (39)
 Endometriosis 104 (17) 6 (33)
 Cervical dysplasia 47 (8) 2 (11)
 Uterine prolaps 46 (8) 2 (11)
 Other 43 (7) 1 (6)
Median (min–max)
Surgical parameters
 Duration of surgery (min) 107 (40–390) 104 (47–281) 0.51
 Hemoglobin drop (g/dl) 1.2 (0–6.9) 1.3 (0–3.7) 0.6
 Postoperative hospitalization (days) 3 (1–25) 4 (2–14) 0.29
 Uterine weigth (g) 171 (19–2148) 91 (55–321)  ≤ 0.01
N (%)
 Adhesiolysis 268 (45) 6 (33) 0.34
 Ureterolysis 278 (46) 9 (50) 0.76
Surgeons laparoscopic expertise  ≤ 0.01
 GESEA Level I 283 (47) 14 (78)
 GESEA Level II 316 (53) 4 (22)
Suturing technique 0.22
 Single knot suture 502 (84) 17 (94)
 Running suture 97 (16) 1 (6)
 First postoperative sexual intercourse < 6 weeks 126 (21) 2 (11) 0.26
Table 5  Multivariate analysis of factors associated with the incidence 
of vaginal cuff dehiscence
Odds ratio (95% CI) P
Surgeons laparoscopic 
expertise (GESEA level I 
vs. level II)
3.19 (1.0–9.38) 0.03
Uterine weigth (g) 0.99 (0.98–0.99) 0.02
Suturing technique (single-
knot suture vs. running 
suture)
2.83 (0.37–21.87) 0.32
BMI (kg/m2) 0.97 (9.0–1.05) 0.47
Duration of surgery (min) 0.99 (9.99–1.01) 0.59
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vaginal cuff dehiscence rates described in the literature of 
0.64–5.4%. Low surgeon laparoscopic expertise and low 
uterine weight were identified as risk factors for VCD. 
Two recent studies investigated this subject using similar 
designs [8, 11].
Rettermaier et  al. conducted a retrospective analysis 
including 1876 patients undergoing TLH or robotic-assisted 
laparoscopic hysterectomy at a single institution and found 
a VCD incidence rate of 0.75% (n = 14), which was lower 
than in this study (2.9%). These discrepancies may be, pos-
sibly related to differences in study design. Two-thirds of 
procedures in that study were robotic-assisted laparoscopic 
hysterectomies, for which lower VCD rates (0.4–4.1%) have 
been reported than for laparoscopic hysterectomy [21, 22]. 
In addition, the authors used barbed sutures for vaginal 
vault closure in most cases (no VCD occurred following 
this approach) and identified Vicryl suture use as a VCD 
risk factor [8]. Given the growing body of evidence con-
firming the protective effect of the usage of barbed suture 
to prevent VCD, this might be a further explanation for the 
low VCD rate observed by the authors [23–25]. Finally, 
Rettermaier et al. identified VCD cases using coding data, 
which might have introduced selection bias and led to VCD 
underreporting due to inadequate procedure coding and loss 
to follow-up.
In a retrospective multi-institutional analysis including 
12,398 patients undergoing hysterectomy (laparoscopic, 
vaginal or abdominal), the VCD rate was significantly higher 
for TLH (0.64%) than for abdominal and vaginal hyster-
ectomies (0.2% and 0.13%), respectively, and laparoscopic 
vaginal cuff closure during TLH (performed in 20/38 VCD 
cases) was the main risk factor for VCD [11]. The VCD rate 
for TLH with vaginal closure (0.24%) was similar to those 
for abdominal and vaginal hysterectomies. Differences in 
the VCD rate between that study and ours might be due to 
differences in assessment of VCD and follow-up. Surgeons’ 
laparoscopic expertise may also have contributed, although 
the authors did not provide such information.
Higher VCD rates following TLH with laparoscopic (vs. 
vaginal) vault closure have been reported in institutions 
with moderate laparoscopic expertise [26]. On the contrary, 
a prospective randomized trial conducted by the Italian 
Society of Gynecologic Endoscopy including only high-
volume (> 500 gynecological interventions/year) Italian 
referral centers [27]. These results are in line with our find-
ing that greater laparoscopic expertise showed a protective 
effect against incidence of VCD. Surgeon’s experience with 
a surgical technique has been shown to have major impact 
on surgical outcomes and complication rates [20, 28]. Par-
ticularly laparoscopic suturing requires advanced training, 
and low proficiency may compromise the quality of vaginal 
cuff closure. Thus, reported differences in the incidence of 
VCD according to surgical technique might reflect surgeons’ 
expertise with the respective surgical approach, underlining 
the importance of training programs for minimally invasive 
surgeries [29].
We identified an inverse association between uterine 
weight and the incidence of VCD, which to our knowledge 
has not been reported previously [11, 29]. Greater mean 
uterine weights (> 300 g) in VCD groups in previous stud-
ies assessing VCD rates discussed above, compared to the 
median weight of 120 g in the VCD group reported in our 
study, may have prevented identification of this variable as 
a risk factor. Our finding may be explained by the use of a 
small uterine-manipulator portio cap (32 mm) for patients 
with small uteri.
The usage of the small cap might lead to two possible 
complications explaining the higher VCD rate in this group. 
First in some cases, the small cap does not fully enclose 
the whole cervix, leading to vaginal vault opening above 
the level of the vaginal fornix, leaving cervical tissue in the 
vaginal vault (Fig. 1). This tissue might not adapt well, lead-
ing to necrosis and a higher VCD rate. In addition, smaller 
vaginal-tissue resection in patients with smaller uterus har-
bors the danger of greater thermal damage. These observa-
tions should be kept in mind for women with smaller uterus, 
who are typically not regarded as being at increased risk 
of postoperative complications. Special attention should be 
given to uterine-manipulator cap selection in these patients 
and cap placement should be checked for full uterine portio 
enclosure after uterine-manipulator application.
This study has several limitations. It was retrospective and 
may have involved reporting bias. However, patient identifi-
cation from a prospectively maintained service database, and 
Fig. 1  Different portio caps used for total laparoscopic hysterectomy 
((1)–32 mm, (2)–35 mm, and (3)–40 mm)
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the standardized follow-up, enhanced the study design and 
minimized the risk of VCD underreporting. This approach 
might also explain the higher VCD incidence than reported 
previously. Moreover, due to our standardized use of surgical 
suturing material, our findings might not be applicable to 
different suturing circumstances. Giving the possible protec-
tive effect of barbed suture use on VCD, this might impact 
the future incidence of VCD [8, 23, 24].
Since the median interval between surgery and occur-
rence of VCD were 12 days (0–69), most VCD were detected 
before the follow-up visit 6 weeks postoperatively and an 
earlier follow-up might have been more accurate. Another 
limitation of this study is the sample size. Although our sam-
ple was not small relative to those of other studies address-
ing similar questions, the rareness of VCD renders its statis-
tical correlation with risk factors difficult [9, 24].
Conclusion
We found a VCD rate of 2.9% in this homogenous cohort 
treated with TLH for benign uterine pathologies at a single 
institution with a standardized follow-up and identified low 
surgeon’s laparoscopic expertise and low uterine weight as 
factors associated with an increased risk of VCD. These 
findings emphasize the influence of surgeon’s experience 
on the occurrence of VCD and help to identify patients with 
small uterus as an at-risk population. Our observations pro-
vide insight to minimize the risk of VCD, but additional 
prospective research is needed.
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